CD8A and colorectal carcinoma: Moreover, these studies do not systematically include all ICs, particularly one of the most recently described members of this family, namely NKG2A (Natural Killer group protein 2A) [20], which we have previously shown to negatively impact the anti-tumor CD8 T-cell response in CRC [21].